<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-27018" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Peripheral Vascular Bypass</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Young</surname>
            <given-names>Jacob</given-names>
          </name>
          <aff>LSU School of Medicine - New Orleans</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lotfollahzadeh</surname>
            <given-names>Saran</given-names>
          </name>
          <aff>Vascular Reserach, Department of Medicine, Boston University School of Medicine, Boston, MA 02118, USA, Department of Surgery, vascular and endovascular surgery section, Boston Medical Center, Boston, MA</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Patel</surname>
            <given-names>Shivik K.</given-names>
          </name>
          <aff>LSUHSC</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Jacob Young declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Saran Lotfollahzadeh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Shivik Patel declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>14</day>
          <month>8</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-27018.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Peripheral vascular bypass (PVB) is the surgical revision of blood flow to restore perfusion distal to an occluded or otherwise disrupted arterial segment. Peripheral vascular bypass procedures can involve any arteries, excluding those in the heart or the brain. Most patients with PAD are asymptomatic, and their risk for limb loss is negligible. Therefore intervention is not indicated in asymptomatic patients. However, symptomatic patients might present with claudication and rest pain. A significant subset of patients with symptomatic PAD present with chronic limb-threatening ischemia (CLTI). This activity describes the different types of peripheral vascular bypass surgery and highlights the interprofessional team's role in managing patients undergoing this procedure.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Describe the indications for peripheral vascular bypass.</p></list-item><list-item><p>Review the contraindications to peripheral vascular bypass.</p></list-item><list-item><p>Review the surgical technique for one of the bypass surgical procedures discussing the aortoiliac disease.</p></list-item><list-item><p>Explain interprofessional team strategies for enhancing care coordination and communication to advance the management of patients with peripheral vascular disease and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27018&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27018">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-27018.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Peripheral vascular bypass (PVB) is the surgical revision of blood flow to restore perfusion distal to an occluded or otherwise disrupted arterial segment. PVB procedures can involve any arteries, excluding those in the heart or the brain. Vascular surgeons typically do these open surgical procedures.<xref ref-type="bibr" rid="article-27018.r1">[1]</xref><xref ref-type="bibr" rid="article-27018.r2">[2]</xref><xref ref-type="bibr" rid="article-27018.r3">[3]</xref></p>
        <p>Most patients with PAD are asymptomatic, and their risk for limb loss is negligible. Therefore intervention is&#x000a0;not&#x000a0;indicated in asymptomatic patients. However, symptomatic patients might present with claudication and rest pain. A significant subset of patients with symptomatic PAD present with chronic limb-threatening ischemia (CLTI).<xref ref-type="bibr" rid="article-27018.r4">[4]</xref></p>
      </sec>
      <sec id="article-27018.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>PVB procedures can be accomplished via anastomosis with any of the main arteries except those located in the head.<xref ref-type="bibr" rid="article-27018.r5">[5]</xref><xref ref-type="bibr" rid="article-27018.r6">[6]</xref><xref ref-type="bibr" rid="article-27018.r7">[7]</xref></p>
        <p>Arteries within the upper extremity and chest that may require bypass include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Subclavian artery</bold> &#x02013; located between the anterior and medial scalene muscles</p>
          </list-item>
          <list-item>
            <p><bold>Axillary artery</bold> &#x02013; originating at the lateral aspect of the first rib</p>
          </list-item>
          <list-item>
            <p><bold>Brachial artery</bold> &#x02013; a continuation of the axillary artery as it passes the inferior margin of the teres major muscle, which bifurcates at the level of the antecubital fossa into the radial and ulnar arteries</p>
          </list-item>
          <list-item>
            <p><bold>Radial artery</bold> &#x02013; located on the lateral aspect of the ventral lower arm</p>
          </list-item>
          <list-item>
            <p><bold>Ulnar artery</bold> &#x02013; located on the medial aspect of the ventral lower arm</p>
          </list-item>
        </list>
        <p>Arteries often bypassed within the lower extremity include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Common Femoral Artery</bold> &#x02013; a continuation of the external iliac artery, running into the thigh distal to the inguinal ligament</p>
          </list-item>
          <list-item>
            <p><bold>Superficial Femoral Artery</bold> &#x02013; the continuation of the common femoral artery after it gives off the profunda femoris artery</p>
          </list-item>
          <list-item>
            <p><bold>Popliteal artery</bold> &#x02013; a continuation of the superficial femoral artery after passing through the abductor canal, running dorsally and medially in the popliteal fossa, and then bifurcating into the anterior tibial, posterior tibial, and peroneal arteries</p>
          </list-item>
          <list-item>
            <p><bold>Anterior Tibial Artery &#x02013; </bold>courses through the anterior compartment of the leg, having originated posterior to the tibia at the distal aspect of the popliteus muscle</p>
          </list-item>
          <list-item>
            <p><bold>Posterior Tibial Artery &#x02013; </bold>courses through the posterior compartment of the leg, having originated at the tibial-peroneal trunk from the popliteal artery</p>
          </list-item>
          <list-item>
            <p><bold>Peroneal (Fibular) Artery &#x02013; </bold>courses through the lateral compartment of the leg, originating at the tibial-peroneal trunk from the popliteal artery</p>
          </list-item>
        </list>
        <p>Arteries often bypassed with the abdomen include:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Abdominal Aorta &#x02013; </bold>a continuation of the thoracic aorta after passing through the diaphragm at the level of T12</p>
          </list-item>
          <list-item>
            <p><bold>Common Iliac &#x02013; </bold>arises from the bifurcation of the aorta at the level of the 4 Lumbar Vertebrae</p>
          </list-item>
          <list-item>
            <p><bold>External Iliac &#x02013; </bold>a continuation of the common iliac, following the medial aspect of the psoas major muscles</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27018.s4" sec-type="Indications">
        <title>Indications</title>
        <p>PVB is applied in managing certain traumatic arterial injuries, or aneurysms, and most commonly for peripheral arterial disease (PAD). PAD results from atherosclerotic plaque causing stenosis of the arteries supplying the lower extremities. Symptoms of PAD range from asymptomatic to demand ischemia or claudication to Critical Limb Ischemia (CLI), characterized by severe disability and tissue loss. For these patients, PVB is considered if they have a severe disease burden that is not amenable to endovascular therapy or if they have failed therapy previously. Lesions that are not responsive include severe stenosis and hostile vascular anatomy, which would make endovascular treatment technically challenging.<xref ref-type="bibr" rid="article-27018.r8">[8]</xref><xref ref-type="bibr" rid="article-27018.r9">[9]</xref></p>
        <p>In PAD patients with claudication, revascularization is indicated only for those patients who will derive a functional benefit. For instance, an increase in walking distance is predicted. However, revascularization for disabling claudication is limited to those patients with the more proximal disease, specifically when the iliofemoral or femoropopliteal territory is involved. Accordingly, claudication is not usually considered a robust indication to perform a distal (e.g., femorotibial) bypass. Moreover, distal bypass to a tibial artery for the treatment of claudication is not usually indicated. Assigning the infrapopliteal vessels for the outflow of the bypass should be limited to the patients with CLTI in whom either the femoropopliteal bypass is not feasible or with the absence of direct flow into patent runoff vessels.<xref ref-type="bibr" rid="article-27018.r10">[10]</xref></p>
        <p>It should be noted that in the patients with CLTI signs and symptoms, including rest pain and tissue loss, revascularization is strongly indicated otherwise, as progression to amputation is likely in such cases. Therefore, a form of intervention, either endovascular revascularization or surgical bypass, might be selected. Notwithstanding, CLTI is a considerable indication for intervention; in some patients with less significant stages of the wound, ischemia, and foot Infection stages, supportive management&#x000a0;without revascularization is indicated. Interestingly, as the patients with CLTI are commonly affected with a multilevel arterial occlusive disease involving not only the femoropopliteal but also tibioperoneal segments, lower extremity surgical revascularization bypass addresses both by a common femoral artery to the tibial arteries bypass, however, in patients with diabetes with diffuse and significant below-the-knee disease, a shorter bypass from the superficial femoral artery or popliteal artery is indicated.<xref ref-type="bibr" rid="article-27018.r11">[11]</xref><xref ref-type="bibr" rid="article-27018.r12">[12]</xref><xref ref-type="bibr" rid="article-27018.r13">[13]</xref></p>
      </sec>
      <sec id="article-27018.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>The contraindications for PVB are similar to those for other surgeries. Many patients with peripheral vascular disease have other comorbidities, including cardiac and respiratory dysfunction. Patients with a history of previous cardiac intervention (stenting, angioplasty, or coronary artery bypass) or low ejection fraction have high perioperative mortality. The same holds for patients with respiratory illnesses, such as chronic obstructive pulmonary disease. Thus, any patient undergoing PVB should have and thorough cardiac and respiratory workup before surgery.<xref ref-type="bibr" rid="article-27018.r14">[14]</xref><xref ref-type="bibr" rid="article-27018.r15">[15]</xref><xref ref-type="bibr" rid="article-27018.r16">[16]</xref></p>
      </sec>
      <sec id="article-27018.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>The equipment used in PVB surgery involves many of the same surgical tools as other procedures. However, there are some unique instruments worth mentioning.</p>
        <list list-type="bullet">
          <list-item>
            <p>Tunneler: Used to tunnel bypass conduits through deep tissue</p>
          </list-item>
          <list-item>
            <p>DeBakey Clamps: Used to clamp large vessels temporarily</p>
          </list-item>
          <list-item>
            <p>Bulldog Clamps: Used to clamp medium-sized vessels temporarily</p>
          </list-item>
          <list-item>
            <p>Vessel loops: Rubber loops are used to easily identify vessels and to temporarily occlude them if needed</p>
          </list-item>
          <list-item>
            <p>Doppler: Ultrasound probe that identifies audio waveforms of blood flow</p>
          </list-item>
          <list-item>
            <p>Castro-Viejo: Precision needle driver for passing suture</p>
          </list-item>
          <list-item>
            <p>Prolene Suture: This is the favored suture material for vascular anastomoses. It is a permanent monofilament suture</p>
          </list-item>
          <list-item>
            <p>Heparin: Anticoagulation. Given systemically or locally to prevent clotting during vascular clamping</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-27018.s7" sec-type="Preparation">
        <title>Preparation</title>
        <p>Vascular surgery is considered a high-risk procedure, and most procedures carry a greater than 5% risk of an acute cardiac event. Direct reconstruction of aorta iliofemoral disease is associated with a 2.8% perioperative mortality, while extra-anatomic bypass confers an 8.8% mortality. Mortality increases in patients with chronic obstructive pulmonary disease, advanced age, pre-existing cardiac disease, diabetes, renal failure, and tobacco use. Under this pretense, accurate risk stratification is warranted in patients undergoing PVB.&#x000a0;While most patients are managed under general anesthesia, local and regional anesthesia (RA) provides several possible advantages, including stable cardiovascular hemodynamic perioperative course and improved postoperative pain relief. Moreover, chronic postsurgical pain syndromes are more efficiently prevented by applying local and regional anesthesia methods.<xref ref-type="bibr" rid="article-27018.r17">[17]</xref><xref ref-type="bibr" rid="article-27018.r18">[18]</xref>&#x000a0;According to several retrospective studies, older patients with a medical history of chronic obstructive pulmonary disease are more likely to be managed with regional anesthesia.<xref ref-type="bibr" rid="article-27018.r19">[19]</xref></p>
        <p>Myocardial injury after noncardiac surgery (MINS) is considered an index of cardiac risk stratification in vascular surgery patients. An elevation of fourth-generation troponin T equal to or greater than 0.03 ng/mL is considered significant.<xref ref-type="bibr" rid="article-27018.r20">[20]</xref>&#x000a0;Patients with MINS have a significantly higher 30-day postoperative mortality. Almost 75% of the vascular surgical patients with MINS were asymptomatic without remarkable evidence of myocardial ischemia. Postoperative troponin rise predicts a 26 percent decrease in the 5-year survival post-operatively. However, the presence of a significant postoperative myocardial infarction predicts a 55 percent reduction in survival in a five-year follow-up. Management of cardiac medications, including&#x000a0;beta blockers, angiotensin-converting enzyme inhibitors, and alpha-agonists, e.g., clonidine and anti-platelets, should be prioritized.<xref ref-type="bibr" rid="article-27018.r21">[21]</xref></p>
        <p>Patients with a medical history of chronic kidney disease (CKD) are at increased risk for contrast-induced and contrast-associated nephropathy. Therefore, a baseline creatinine level and re-check in the immediate preoperative period are mandatory. The patients who are subjected to angiography should be well-hydrated. Accordingly, intravenous hydration with 1 mL/kg/hour of isotonic saline&#x000a0;for 6 to 12 hours pre and peri-procedure are recommended. The hydration protocols should be continued for 6 to 12 hours post-operatively.<xref ref-type="bibr" rid="article-27018.r22">[22]</xref></p>
      </sec>
      <sec id="article-27018.s8" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>
<bold>Methods</bold>
</p>
        <p>PVB procedures can vary depending on patient anatomy and the location of the arterial obstruction. However, in most cases, there are common configurations to redirect the flow. The key to a functional bypass is establishing the proximal and distal anastomoses in disease-free regions. The following technique describes the aortoiliac disease. However, the principles for surgical interventions in other anatomical involvement are consistent.</p>
        <p><bold>Aortoiliac disease:</bold> An iliofemoral bypass, which connects the ipsilateral or contralateral iliac artery to the common femoral artery (CFA), can be employed.Bilateral aortoiliac disease: An aortobifemoral bypass connects the abdominal aorta with bilateral CFA to bypass the occlusion. An axillary-femoral bypass may be considered if a patient fails this intervention or has a contraindication for the procedure. In this procedure, the axillary artery is first connected to the ipsilateral CFA, which is then connected to the contralateral CFA. For an open technique, the patient positioning is supine with arms abducted to 90 degrees. The patient should undergo prepping from the nipples to the knees. The CFA, superficial, and deep femoral arteries bilaterally are isolated through bilateral groin incisions. It is essential to be sure that the distal portions of&#x000a0;the vessels are soft, so they are suitable for clamping. Aortic exposure is typically through a midline incision (transperitoneal approach); however, some prefer a retroperitoneal or transverse incision.</p>
        <p>The retroperitoneum is entered, typically infracolically and after the duodenum is mobilized to the right. The aorta gets dissected below the level of the renal arteries. Most try to remain to the right of the inferior mesenteric vein to avoid violating the left mesocolon. The renal vein can be mobilized by ligation of its tributaries. Exposure of the aorta needs to be taken down to the level of the inferior mesenteric artery. Tunnels within the retroperitoneum, posterior to the ureters, are carried down to the groin incisions. On the left side, the tunnel is often brought posterior to the inferior mesenteric artery to help with keeping the graft isolated from the left mesocolon.<xref ref-type="bibr" rid="article-27018.r23">[23]</xref>Heparin is administered (70 to 100 units/kg) with a goal of ACT of 250 to 300 seconds, and the aorta is clamped below the renal arteries and on the distal portion already exposed.<xref ref-type="bibr" rid="article-27018.r24">[24]</xref></p>
        <p>The surgeon divides the aorta and a portion resected proximal to the inferior mesenteric artery. The distal aorta is oversewn. The chosen graft is anastomosed to the proximal aorta, most commonly in an end-to-end fashion using a 3-0 or 4-0 running permanent suture.</p>
        <p>The limbs of the graft are then flushed with heparinized saline, clamped, and passed through the tunnels into the groin incisions. Clamps are applied to the CFA, and an arteriotomy is made, sometimes down to the level of the profunda, thus&#x000a0;requiring a profundaplasty. Endarterectomy follows, if necessary. The graft is anastomosed to the CFA in an end-to-side running manner, usually with a 4-0 or 5-0 permanent suture. Before completion of the anastomosis, usual back bleeding, forward bleeding, and flushing are employed. The opposite femoral artery is&#x000a0;addressed similarly. Blood flow is restored to the CFA, then the profunda femoris, and lastly, the superficial femoral artery. However, before unclamping, anesthesia should be notified because of the expected hypotension with reperfusion. The retroperitoneum should be closed in layers to adequately omit the graft from the GI tract. If unable to sufficiently close the retroperitoneum, an omental flap should be created.<xref ref-type="bibr" rid="article-27018.r23">[23]</xref><xref ref-type="bibr" rid="article-27018.r25">[25]</xref></p>
        <p>End-to-end anastomosis is preferred because it allows the graft to lie flatter and thus may lessen the chance of future aortoenteric fistula. This method also better allows for retrograde perfusion into the inferior mesenteric artery. However, in cases with bilateral external iliac artery occlusion, an end-to-side or formal reconstruction of one of the IIA is needed to ensure blood flow delivery to the pelvis.<xref ref-type="bibr" rid="article-27018.r24">[24]</xref></p>
        <p>Conduits for bypass include artificial grafts (polytetrafluoroethylene and Dacron) and autologous saphenous vein (reversed, non-reversed, and&#x000a0;<italic toggle="yes">in situ</italic>). For most infra-inguinal bypasses, an autologous vein graft is preferred. Aortoiliac bypasses require conduits with a larger lumen. Thus synthetic grafts are commonly used.</p>
      </sec>
      <sec id="article-27018.s9" sec-type="Complications">
        <title>Complications</title>
        <p>Patients undergoing PVB risk wound infection, bleeding, pneumonia, conduit occlusion, and peripheral nerve damage. These patients often also have a higher prevalence of cerebrovascular and coronary artery disease, significantly increasing their risk for stroke and myocardial infarction surgery. Indicators for potential adverse outcomes include smoking, pulmonary disease, female sex, diabetes mellitus, previous bypass history, and advanced age. Conduit-related complications can be divided into immediate and long-term. Immediate, including acute thrombosis and bleeding. Long-term, including infection and occlusion secondary to intimal hyperplasia. &#x000a0;</p>
      </sec>
      <sec id="article-27018.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The patient's distal flow to posterior tibial and dorsalis pedis should be assessed. If the pulses are not palpable, a doppler should to used for identification. Patients should be discharged on a statin, along with aspirin and/or clopidogrel. If they have a synthetic conduit, dual therapy should be considered. Follow-up should include periodic evaluations of symptoms, pedal pulses, and the ankle-brachial index. Duplex ultrasound is the best non-invasive technique to assess graft patency.</p>
      </sec>
      <sec id="article-27018.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>PVB can help perfuse obstructed limbs. However, peripheral vascular disease is a progressive disorder with no cure. Clinicians (MDs, DOs, NPs, and PAs), nurses, and pharmacists, operating as an interprofessional healthcare team should educate patients on preventing PVD. This means discontinuing smoking, maintaining a healthy body weight, controlling diabetes, lowering cholesterol, and remaining physically active. These lifestyle changes have more durable benefits than most bypass procedures.</p>
        <p>PVB is not a benign procedure and is associated with serious complications, including death.</p>
      </sec>
      <sec id="article-27018.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=27018&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=27018">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/27018/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=27018">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-27018.s13">
        <title>References</title>
        <ref id="article-27018.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Siah</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Abramowitz</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Perfusion Assessment and Treatment in the Diabetic Patient.</article-title>
            <source>Clin Podiatr Med Surg</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>36</volume>
            <issue>3</issue>
            <fpage>361</fpage>
            <page-range>361-370</page-range>
            <pub-id pub-id-type="pmid">31079603</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shukla</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Callas</surname>
                <given-names>PW</given-names>
              </name>
              <name>
                <surname>Lahiri</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Alef</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Keating</surname>
                <given-names>FK</given-names>
              </name>
              <name>
                <surname>Stanley</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Steinthorsson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Bertges</surname>
                <given-names>DJ</given-names>
              </name>
            </person-group>
            <article-title>Surveillance and Management of Troponin Elevation after Vascular Surgery.</article-title>
            <source>Ann Vasc Surg</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>60</volume>
            <fpage>156</fpage>
            <page-range>156-164</page-range>
            <pub-id pub-id-type="pmid">31075460</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yanagisawa</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Gomes</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Menting</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>De Loose</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Varcoe</surname>
                <given-names>RL</given-names>
              </name>
            </person-group>
            <article-title>The current state of surgical bypass versus drug eluting stents for long femoropopliteal occlusive lesions.</article-title>
            <source>J Cardiovasc Surg (Torino)</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>60</volume>
            <issue>4</issue>
            <fpage>450</fpage>
            <page-range>450-455</page-range>
            <pub-id pub-id-type="pmid">31062570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cyrek</surname>
                <given-names>AE</given-names>
              </name>
              <name>
                <surname>Henn</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Meinhardt</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lainka</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pacha</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Koch</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Improving Limb Salvage for Chronic Limb-Threatening Ischemia With Spinal Cord Stimulation: A Retrospective Analysis.</article-title>
            <source>Vasc Endovascular Surg</source>
            <year>2021</year>
            <month>May</month>
            <volume>55</volume>
            <issue>4</issue>
            <fpage>367</fpage>
            <page-range>367-373</page-range>
            <pub-id pub-id-type="pmid">33550918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Powell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Farber</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rosenfield</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Goodney</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Lookstein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pena</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schermerhorn</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Comparison of specialties participating in the BEST-CLI trial to specialists treating peripheral arterial disease nationally.</article-title>
            <source>J Vasc Surg</source>
            <year>2019</year>
            <month>May</month>
            <volume>69</volume>
            <issue>5</issue>
            <fpage>1505</fpage>
            <page-range>1505-1509</page-range>
            <pub-id pub-id-type="pmid">31010516</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Levin</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Arinze</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Siracuse</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Lower extremity critical limb ischemia: A review of clinical features and management.</article-title>
            <source>Trends Cardiovasc Med</source>
            <year>2020</year>
            <month>Apr</month>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>125</fpage>
            <page-range>125-130</page-range>
            <pub-id pub-id-type="pmid">31005554</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Markovic</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Cvetkovic</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Koncar</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>Dragas</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Markovic</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Kukic</surname>
                <given-names>BP</given-names>
              </name>
              <name>
                <surname>Kuzmanovic</surname>
                <given-names>IB</given-names>
              </name>
              <name>
                <surname>Dimic</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Sladojevic</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Davidovic</surname>
                <given-names>LB</given-names>
              </name>
            </person-group>
            <article-title>Treatment of pediatric vascular injuries: the experience of a single non-pediatric referral center.</article-title>
            <source>Int Angiol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>38</volume>
            <issue>3</issue>
            <fpage>250</fpage>
            <page-range>250-255</page-range>
            <pub-id pub-id-type="pmid">30994319</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Qiao</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Impact of risk factors and surgical techniques in coronary endarterectomy: a network meta-analysis.</article-title>
            <source>Interact Cardiovasc Thorac Surg</source>
            <year>2019</year>
            <month>Sep</month>
            <day>01</day>
            <volume>29</volume>
            <issue>3</issue>
            <fpage>355</fpage>
            <page-range>355-364</page-range>
            <pub-id pub-id-type="pmid">30982903</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Phair</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Carnevale</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Teveris</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Koleilat</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Indes</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Peripheral arterial occlusive disease operative case volume in the final years of 5+2 and 0+5 vascular training paradigms.</article-title>
            <source>Surgery</source>
            <year>2019</year>
            <month>Aug</month>
            <volume>166</volume>
            <issue>2</issue>
            <fpage>198</fpage>
            <page-range>198-202</page-range>
            <pub-id pub-id-type="pmid">30967238</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Betz</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ingolf</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Markus</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Florian</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Christian</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>Evaluation of Long-Term Outcomes of Femoropopliteal Bypass Surgery in Patients With Chronic Limb-Threatening Ischemia in an Endovascular Era.</article-title>
            <source>Ann Vasc Surg</source>
            <year>2022</year>
            <month>Feb</month>
            <volume>79</volume>
            <fpage>191</fpage>
            <page-range>191-200</page-range>
            <pub-id pub-id-type="pmid">34644653</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conte</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Bradbury</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Kolh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Dick</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fitridge</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mills</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ricco</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Suresh</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Aboyans</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Aksoy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alexandrescu</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Azuma</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Belch</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bergoeing</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bjorck</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chakf&#x000e9;</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dawson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Debus</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Dueck</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Duval</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eckstein</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Ferraresi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gambhir</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Garguilo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Geraghty</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Goode</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Hinchliffe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jetty</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Komori</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lavery</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lookstein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miyata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Moneta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Munoa Prado</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Munoz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paolini</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pomposelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Robless</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schanzer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vega de Ceniga</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Veller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vermassen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <collab>GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS)</collab>
              <collab>European Society for Vascular Surgery (ESVS), and World Federation of Vascular Societies (WFVS)</collab>
            </person-group>
            <article-title>Corrigendum to 'Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia' [European Journal of Vascular &#x00026; Endovascular Surgery 58/1S (2019) 1-109].</article-title>
            <source>Eur J Vasc Endovasc Surg</source>
            <year>2020</year>
            <month>Mar</month>
            <volume>59</volume>
            <issue>3</issue>
            <fpage>492</fpage>
            <page-range>492-493</page-range>
            <pub-id pub-id-type="pmid">31836510</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conte</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Bradbury</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Kolh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Dick</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fitridge</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mills</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ricco</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Suresh</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Aboyans</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Aksoy</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alexandrescu</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Armstrong</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Azuma</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Belch</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bergoeing</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bjorck</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Chakf&#x000e9;</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Cheng</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dawson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Debus</surname>
                <given-names>ES</given-names>
              </name>
              <name>
                <surname>Dueck</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Duval</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Eckstein</surname>
                <given-names>HH</given-names>
              </name>
              <name>
                <surname>Ferraresi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gambhir</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Gargiulo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Geraghty</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Goode</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Gray</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Gupta</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Hinchliffe</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Jetty</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Komori</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lavery</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Liang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Lookstein</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Menard</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Misra</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Miyata</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Moneta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Munoa Prado</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Munoz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Paolini</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pomposelli</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Powell</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Robless</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rogers</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Schanzer</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>De Ceniga</surname>
                <given-names>MV</given-names>
              </name>
              <name>
                <surname>Veller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vermassen</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>S</given-names>
              </name>
              <collab>GVG Writing Group for the Joint Guidelines of the Society for Vascular Surgery (SVS), European Society for Vascular Surgery (ESVS), and World Federation of Vascular Societies (WFVS)</collab>
            </person-group>
            <article-title>Global Vascular Guidelines on the Management of Chronic Limb-Threatening Ischemia.</article-title>
            <source>Eur J Vasc Endovasc Surg</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>58</volume>
            <issue>1S</issue>
            <fpage>S1</fpage>
            <page-range>S1-S109.e33</page-range>
            <pub-id pub-id-type="pmid">31182334</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conte</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Bradbury</surname>
                <given-names>AW</given-names>
              </name>
              <name>
                <surname>Kolh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>White</surname>
                <given-names>JV</given-names>
              </name>
              <name>
                <surname>Dick</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Fitridge</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mills</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Ricco</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Suresh</surname>
                <given-names>KR</given-names>
              </name>
              <name>
                <surname>Murad</surname>
                <given-names>MH</given-names>
              </name>
              <collab>GVG Writing Group</collab>
            </person-group>
            <article-title>Global vascular guidelines on the management of chronic limb-threatening ischemia.</article-title>
            <source>J Vasc Surg</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>69</volume>
            <issue>6S</issue>
            <fpage>3S</fpage>
            <page-range>3S-125S.e40</page-range>
            <pub-id pub-id-type="pmid">31159978</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lewinger</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Wolfson</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Shavelle</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Weaver</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Preoperative hemoglobin A1c levels and increased risk of adverse limb events in diabetic patients undergoing infrainguinal lower extremity bypass surgery in the Vascular Quality Initiative.</article-title>
            <source>J Vasc Surg</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>70</volume>
            <issue>4</issue>
            <fpage>1225</fpage>
            <page-range>1225-1234.e1</page-range>
            <pub-id pub-id-type="pmid">30852042</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Khan</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Brienesse</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Boyle</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Percutaneous treatment of saphenous vein graft aneurysm: Contemporary procedural considerations.</article-title>
            <source>Catheter Cardiovasc Interv</source>
            <year>2019</year>
            <month>Apr</month>
            <day>01</day>
            <volume>93</volume>
            <issue>5</issue>
            <fpage>927</fpage>
            <page-range>927-932</page-range>
            <pub-id pub-id-type="pmid">30737966</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Forster</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Liew</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bhattacharya</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Shaw</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Stansby</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Gene therapy for peripheral arterial disease.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2018</year>
            <month>Oct</month>
            <day>31</day>
            <volume>10</volume>
            <issue>10</issue>
            <fpage>CD012058</fpage>
            <pub-id pub-id-type="pmid">30380135</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bouman</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Dortangs</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Buhre</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Gramke</surname>
                <given-names>HF</given-names>
              </name>
            </person-group>
            <article-title>Current techniques and strategies for anesthesia in patients undergoing peripheral bypass surgery.</article-title>
            <source>J Cardiovasc Surg (Torino)</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>55</volume>
            <issue>2 Suppl 1</issue>
            <fpage>207</fpage>
            <page-range>207-16</page-range>
            <pub-id pub-id-type="pmid">24796915</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guimar&#x000e3;es</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Angonese</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Gomes</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Junior</surname>
                <given-names>VM</given-names>
              </name>
              <name>
                <surname>Farias</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>[Anesthesia for lower extremity vascular bypass with peripheral nerve block].</article-title>
            <source>Rev Bras Anestesiol</source>
            <year>2017</year>
            <season>Nov-Dec</season>
            <volume>67</volume>
            <issue>6</issue>
            <fpage>626</fpage>
            <page-range>626-631</page-range>
            <pub-id pub-id-type="pmid">26817796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ghanami</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Hurie</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Andrews</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Harrington</surname>
                <given-names>RN</given-names>
              </name>
              <name>
                <surname>Corriere</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Goodney</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Hansen</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Edwards</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Anesthesia-based evaluation of outcomes of lower-extremity vascular bypass procedures.</article-title>
            <source>Ann Vasc Surg</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>199</fpage>
            <page-range>199-207</page-range>
            <pub-id pub-id-type="pmid">22944010</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Biccard</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>DJA</given-names>
              </name>
              <name>
                <surname>Chan</surname>
                <given-names>MTV</given-names>
              </name>
              <name>
                <surname>Archbold</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Sigamani</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Urr&#x000fa;tia</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Cruz</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Srinathan</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Szalay</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Harlock</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Tittley</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Rapanos</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Elias</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jacka</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Malaga</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Berwanger</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Montes</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Heels-Ansdell</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Hutcherson</surname>
                <given-names>MT</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>CK</given-names>
              </name>
              <name>
                <surname>Polanczyk</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Szczeklik</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ackland</surname>
                <given-names>GL</given-names>
              </name>
              <name>
                <surname>Dubois</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Sapsford</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Williams</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cort&#x000e9;s</surname>
                <given-names>OL</given-names>
              </name>
              <name>
                <surname>Le Mananch</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Devereaux</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Myocardial Injury After Noncardiac Surgery (MINS) in Vascular Surgical Patients: A Prospective Observational Cohort Study.</article-title>
            <source>Ann Surg</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>268</volume>
            <issue>2</issue>
            <fpage>357</fpage>
            <page-range>357-363</page-range>
            <pub-id pub-id-type="pmid">28486392</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simons</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Baril</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Goodney</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Bertges</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Robinson</surname>
                <given-names>WP</given-names>
              </name>
              <name>
                <surname>Cronenwett</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Messina</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Schanzer</surname>
                <given-names>A</given-names>
              </name>
              <collab>Vascular Study Group of New England</collab>
            </person-group>
            <article-title>The effect of postoperative myocardial ischemia on long-term survival after vascular surgery.</article-title>
            <source>J Vasc Surg</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>58</volume>
            <issue>6</issue>
            <fpage>1600</fpage>
            <page-range>1600-8</page-range>
            <pub-id pub-id-type="pmid">23910457</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rein</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Coca</surname>
                <given-names>SG</given-names>
              </name>
            </person-group>
            <article-title>"I don't get no respect": the role of chloride in acute kidney injury.</article-title>
            <source>Am J Physiol Renal Physiol</source>
            <year>2019</year>
            <month>Mar</month>
            <day>01</day>
            <volume>316</volume>
            <issue>3</issue>
            <fpage>F587</fpage>
            <page-range>F587-F605</page-range>
            <pub-id pub-id-type="pmid">30539650</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guo</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Gu</surname>
                <given-names>YQ</given-names>
              </name>
              <name>
                <surname>Qi</surname>
                <given-names>LX</given-names>
              </name>
              <name>
                <surname>Tong</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Guo</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>ZG</given-names>
              </name>
            </person-group>
            <article-title>Totally laparoscopic bypass surgery for aortoiliac occlusive disease in China.</article-title>
            <source>Chin Med J (Engl)</source>
            <year>2013</year>
            <month>Aug</month>
            <volume>126</volume>
            <issue>16</issue>
            <fpage>3069</fpage>
            <page-range>3069-72</page-range>
            <pub-id pub-id-type="pmid">23981614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r24">
          <label>24</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Dellehunt</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Manna</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <chapter-title>Aortofemoral Bypass</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>4</month>
            <day>19</day>
            <pub-id pub-id-type="pmid">31194468</pub-id>
          </element-citation>
        </ref>
        <ref id="article-27018.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Clair</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Beach</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Strategies for managing aortoiliac occlusions: access, treatment and outcomes.</article-title>
            <source>Expert Rev Cardiovasc Ther</source>
            <year>2015</year>
            <month>May</month>
            <volume>13</volume>
            <issue>5</issue>
            <fpage>551</fpage>
            <page-range>551-63</page-range>
            <pub-id pub-id-type="pmid">25907618</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
